Cell Signalling and Inflammation in Cancer
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".
Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 31546
Special Issue Editors
Interests: NF-kB signalling; inflammation; cancer; cancer metabolism
Interests: NF-kB signalling; inflammation; cancer; tumor microenvironment
Special Issue Information
Dear Colleagues,
Inflammation is an evolutionarily conserved process, which is well known for its essential role in host defence, tissue repair, regeneration, and remodelling.
Over the last few decades, the contribution of inflammation to cancer development, progression, and therapy has been widely recognised. While the induction of acute inflammation often suppresses tumour progression, the onset of chronic inflammation fosters tumorigenesis and therapy resistance. Hence, tumour-promoting inflammation is a hallmark of cancer. The source of this chronic inflammation in cancer has been ascribed to the progressive activation over time of immune cells, mostly of the innate arm of the immune system, which interact with cancer and stromal cells, thus building up an inflammatory and immunosuppressive tumour microenvironment (TME).
Multiple signalling pathways, as well as inflammatory cytokines, chemokines, growth factors, and metabolites, are key orchestrators of inflammation-mediated tumour progression.
In this Special Issue, we welcome reviews and original articles focused on molecular and cellular signalling pathways linking inflammation and cancer.
Dr. Daria Capece
Dr. Daniela Verzella
Dr. Davide Vecchiotti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell signalling
- inflammation
- cancer
- tumour microenvironment
- genetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.